Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation
Clinical trial NCT00953706 · TERMINATED
Trial details
- NCT number
- NCT00953706
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-07-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.